Monitoring

Plans for appropriate follow-up should be made. The patient should be reassessed after a trial of monotherapy with an intranasal corticosteroid or oral antihistamine (ideally within 5-7 days).[3]

When symptoms improve, decreasing or discontinuing treatment may be considered.[3][67]

Use of this content is subject to our disclaimer